Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Aviram

Showing results (251-260 of 267) with videos related to

Pageof 27
Sort By:
Clinical and Experimental Immunology|May 1, 1997
Oxidized low-density lipoprotein (Ox-LDL) but not LDL aggravates the manifestations of experimental antiphospholipid syndrome (APS)J George, M Blank, M Hojnik, et al.
Clinical Cardiology|June 1, 1989
Familial homozygous hypercholesterolemia: clinical and cardiovascular features in 18 patientsG J Brook, S Keidar, M Boulos, et al.
Journal of Inherited Metabolic Disease|January 1, 1991
Neutral lipid storage disease with ichthyosis: serum apolipoprotein levels and cholesterol metabolism in monocyte-derived macrophagesR Bergman, M Aviram, O Bitterman-Deutsch, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 9, 1998
Paraoxonase active site required for protection against LDL oxidation involves its free sulfhydryl group and is different from that required for its arylesterase/paraoxonase activities: selective action of human paraoxonase allozymes Q and RM Aviram, S Billecke, R Sorenson, et al.
Genomics|November 4, 1998
The molecular basis of disease variability among cystic fibrosis patients carrying the 3849+10 kb C-->T mutationO Chiba-Falek, E Kerem, T Shoshani, et al.
Molecular and Cellular Biology|March 19, 1999
SAG, a novel zinc RING finger protein that protects cells from apoptosis induced by redox agentsH Duan, Y Wang, M Aviram, et al.
Scientific Reports|February 9, 2016
Novel Osteogenic Ti-6Al-4V Device For Restoration Of Dental Function In Patients With Large Bone Deficiencies: Design, Development And ImplementationD J Cohen, A Cheng, A Kahn, et al.
Pediatric Pulmonology|November 9, 2004
Trampoline use as physiotherapy for cystic fibrosis patientsA Barak, I D Wexler, O Efrati, et al.
Clinical and Experimental Medicine|January 28, 2005
Systemic inflammatory mediators and cystic fibrosis genotypeA Augarten, G Paret, I Avneri, et al.
Pediatrics|January 26, 1999
Clinical and genetic risk factors for cystic fibrosis-related liver diseaseM Wilschanski, J Rivlin, S Cohen, et al.
Pageof 27

Showing results (251-260 of 267) with videos related to

Sort By:
Pageof 27
Clinical and Experimental Immunology|May 1, 1997
Oxidized low-density lipoprotein (Ox-LDL) but not LDL aggravates the manifestations of experimental antiphospholipid syndrome (APS)J George, M Blank, M Hojnik, et al.
Clinical Cardiology|June 1, 1989
Familial homozygous hypercholesterolemia: clinical and cardiovascular features in 18 patientsG J Brook, S Keidar, M Boulos, et al.
Journal of Inherited Metabolic Disease|January 1, 1991
Neutral lipid storage disease with ichthyosis: serum apolipoprotein levels and cholesterol metabolism in monocyte-derived macrophagesR Bergman, M Aviram, O Bitterman-Deutsch, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 9, 1998
Paraoxonase active site required for protection against LDL oxidation involves its free sulfhydryl group and is different from that required for its arylesterase/paraoxonase activities: selective action of human paraoxonase allozymes Q and RM Aviram, S Billecke, R Sorenson, et al.
Genomics|November 4, 1998
The molecular basis of disease variability among cystic fibrosis patients carrying the 3849+10 kb C-->T mutationO Chiba-Falek, E Kerem, T Shoshani, et al.
Molecular and Cellular Biology|March 19, 1999
SAG, a novel zinc RING finger protein that protects cells from apoptosis induced by redox agentsH Duan, Y Wang, M Aviram, et al.
Scientific Reports|February 9, 2016
Novel Osteogenic Ti-6Al-4V Device For Restoration Of Dental Function In Patients With Large Bone Deficiencies: Design, Development And ImplementationD J Cohen, A Cheng, A Kahn, et al.
Pediatric Pulmonology|November 9, 2004
Trampoline use as physiotherapy for cystic fibrosis patientsA Barak, I D Wexler, O Efrati, et al.
Clinical and Experimental Medicine|January 28, 2005
Systemic inflammatory mediators and cystic fibrosis genotypeA Augarten, G Paret, I Avneri, et al.
Pediatrics|January 26, 1999
Clinical and genetic risk factors for cystic fibrosis-related liver diseaseM Wilschanski, J Rivlin, S Cohen, et al.
Pageof 27